Baidu
map

2019 ESC心力衰竭协会射血分数保留心力衰竭诊断共识建议解读

2019-11-30 中国循环杂志.2019,34(z1):72-75.

2007 年欧洲心脏病学会(ESC)心力衰竭协会(HFA)专家共识诊断的主要标准包括:(1)心衰状和(或)体征;(2)左心室收缩功能正常或轻微异常;(3)左心室舒张功能不全。诊断参数包括有创检查、超声心动图数据(如左心室舒张功能及充盈压力、左心室肥厚、左心房增大)、血浆利钠肽水平及心房颤动。但是,这些主要诊断标准的参数数据来源有限,很多患者检查结果处于一个未达到诊断标准的中间区域。而且,对于诊断或

中文标题:

2019 ESC心力衰竭协会射血分数保留心力衰竭诊断共识建议解读

发布机构:

发布日期:

2019-11-30

简要介绍:

2007 年欧洲心脏病学会(ESC)心力衰竭协会(HFA)专家共识诊断的主要标准包括:(1)心衰状和(或)体征;(2)左心室收缩功能正常或轻微异常;(3)左心室舒张功能不全。诊断参数包括有创检查、超声心动图数据(如左心室舒张功能及充盈压力、左心室肥厚、左心房增大)、血浆利钠肽水平及心房颤动。但是,这些主要诊断标准的参数数据来源有限,很多患者检查结果处于一个未达到诊断标准的中间区域。而且,对于诊断或排除HFpEF 的标准不能只依赖于单个高于或低于标准的参数,而应该全面评估患者临床表现、实验室及影像学检查等结果后,方可诊断或排除诊断。

作者:广东省人民医院 丘伟达 黎励文 

拓展指南:心力衰竭相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ESC心力衰竭协会射血分数保留心力衰竭诊断共识建议解读)] GetToolGuiderByIdResponse(projectId=1, id=3c4bc1c00185e96e, title=2019 ESC心力衰竭协会射血分数保留心力衰竭诊断共识建议解读, enTitle=, guiderFrom=中国循环杂志.2019,34(z1):72-75., authorId=null, author=, summary=2007 年欧洲心脏病学会(ESC)心力衰竭协会(HFA)专家共识诊断的主要标准包括:(1)心衰状和(或)体征;(2)左心室收缩功能正常或轻微异常;(3)左心室舒张功能不全。诊断参数包括有创检查、超声心动图数据(如左心室舒张功能及充盈压力、左心室肥厚、左心房增大)、血浆利钠肽水平及心房颤动。但是,这些主要诊断标准的参数数据来源有限,很多患者检查结果处于一个未达到诊断标准的中间区域。而且,对于诊断或, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Nov 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2007 年欧洲心脏病学会(ESC)心力衰竭协会(HFA)专家共识诊断的主要标准包括:(1)心衰状和(或)体征;(2)左心室收缩功能正常或轻微异常;(3)左心室舒张功能不全。诊断参数包括有创检查、超声心动图数据(如左心室舒张功能及充盈压力、左心室肥厚、左心房增大)、血浆利钠肽水平及心房颤动。但是,这些主要诊断标准的参数数据来源有限,很多患者检查结果处于一个未达到诊断标准的中间区域。而且,对于诊断或排除HFpEF 的标准不能只依赖于单个高于或低于标准的参数,而应该全面评估患者临床表现、实验室及影像学检查等结果后,方可诊断或排除诊断。 </P> <P>作者:广东省人民医院 丘伟达 黎励文 </P>拓展指南:<strong>与<font color=red>心力衰竭</font>相关指南:</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=bb4221c00185e865" title="2019 ESC 心力衰竭协会充血性心力衰竭利尿剂使用声明解读" target=_blank>2019 ESC 心力衰竭协会充血性心力衰竭利尿剂使用声明解读</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=e5b441c00185e27f" title="2020 HFA/ESC立场声明:贯穿心力衰竭过程中的肾功能评估" target=_blank>2020 HFA/ESC立场声明:贯穿心力衰竭过程中的肾功能评估</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=5df221c00183839d" title="舒张性心力衰竭诊断和治疗专家共识" target=_blank>舒张性心力衰竭诊断和治疗专家共识</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=f194b1c00183252a" title="慢性心力衰竭基层诊疗指南(实践版·2019)" target=_blank>慢性心力衰竭基层诊疗指南(实践版·2019)</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=0530b1c001832a38" title="慢性心力衰竭基层诊疗指南(2019年)" target=_blank>慢性心力衰竭基层诊疗指南(2019年)</a></li> 更多信息请点击:<a href="//www.sandwebs.com/guideline/list.do?q=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD" target=_blank>有关心力衰竭更多指南</a></ul>, tagList=[TagDto(tagId=56259, tagName=保留射血分数), TagDto(tagId=94550, tagName=心衰诊断)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6952, appHits=548, showAppHits=42, pcHits=2443, showPcHits=5509, likes=63, shares=17, comments=8, approvalStatus=1, publishedTime=Thu Jan 30 01:52:35 CST 2020, publishedTimeString=2019-11-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jan 30 01:52:35 CST 2020, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 14:57:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ESC心力衰竭协会射血分数保留心力衰竭诊断共识建议解读)])
2019 ESC心力衰竭协会射血分数保留心力衰竭诊断共识建议解读
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051290, encodeId=132f105129022, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Tue Sep 14 22:11:14 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907988, encodeId=5bcf90e988cd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyR0jWA7H3MiaB45okXhicCvKW10rMjobB9HyJIxxBgguuqPg8QUiaIKlBGCiatRENTYG2aNwAu8VCZw/132, createdBy=05d25137109, createdName=ms412091436248357, createdTime=Mon Dec 14 22:29:46 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907162, encodeId=547290e16245, content=喜欢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/f0d5290f245743838832bb99a6b4575d/fd8b781d073e45e18ad735129a806782.jpg, createdBy=1e6e5209233, createdName=14757737m09暂无昵称, createdTime=Fri Dec 11 21:24:39 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888410, encodeId=332188841071, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd55421572, createdName=ms7000001606231423, createdTime=Fri Sep 25 22:05:31 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2021-09-14 ms7000001100972409

    很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051290, encodeId=132f105129022, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Tue Sep 14 22:11:14 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907988, encodeId=5bcf90e988cd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyR0jWA7H3MiaB45okXhicCvKW10rMjobB9HyJIxxBgguuqPg8QUiaIKlBGCiatRENTYG2aNwAu8VCZw/132, createdBy=05d25137109, createdName=ms412091436248357, createdTime=Mon Dec 14 22:29:46 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907162, encodeId=547290e16245, content=喜欢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/f0d5290f245743838832bb99a6b4575d/fd8b781d073e45e18ad735129a806782.jpg, createdBy=1e6e5209233, createdName=14757737m09暂无昵称, createdTime=Fri Dec 11 21:24:39 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888410, encodeId=332188841071, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd55421572, createdName=ms7000001606231423, createdTime=Fri Sep 25 22:05:31 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2020-12-14 ms412091436248357

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051290, encodeId=132f105129022, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Tue Sep 14 22:11:14 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907988, encodeId=5bcf90e988cd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyR0jWA7H3MiaB45okXhicCvKW10rMjobB9HyJIxxBgguuqPg8QUiaIKlBGCiatRENTYG2aNwAu8VCZw/132, createdBy=05d25137109, createdName=ms412091436248357, createdTime=Mon Dec 14 22:29:46 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907162, encodeId=547290e16245, content=喜欢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/f0d5290f245743838832bb99a6b4575d/fd8b781d073e45e18ad735129a806782.jpg, createdBy=1e6e5209233, createdName=14757737m09暂无昵称, createdTime=Fri Dec 11 21:24:39 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888410, encodeId=332188841071, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd55421572, createdName=ms7000001606231423, createdTime=Fri Sep 25 22:05:31 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2020-12-11 14757737m09暂无昵称

    喜欢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051290, encodeId=132f105129022, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d945605913, createdName=ms7000001100972409, createdTime=Tue Sep 14 22:11:14 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907988, encodeId=5bcf90e988cd, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyR0jWA7H3MiaB45okXhicCvKW10rMjobB9HyJIxxBgguuqPg8QUiaIKlBGCiatRENTYG2aNwAu8VCZw/132, createdBy=05d25137109, createdName=ms412091436248357, createdTime=Mon Dec 14 22:29:46 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907162, encodeId=547290e16245, content=喜欢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/f0d5290f245743838832bb99a6b4575d/fd8b781d073e45e18ad735129a806782.jpg, createdBy=1e6e5209233, createdName=14757737m09暂无昵称, createdTime=Fri Dec 11 21:24:39 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888410, encodeId=332188841071, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd55421572, createdName=ms7000001606231423, createdTime=Fri Sep 25 22:05:31 CST 2020, time=2020-09-25, status=1, ipAttribution=)]
    2020-09-25 ms7000001606231423

    厉害

    0

Baidu
map
Baidu
map
Baidu
map